CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.

CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.

Show other versions (1)

Convincing correlates of protective immunity against tuberculosis have been elusive. In BALB/c mice, intranasal immunization with a replication-deficient recombinant adenovirus expressing Mycobacterium tuberculosis antigen 85A (adenovirus-85A) induces protective lower respiratory tract immunity agai...

Full description

Bibliographic Details
Main Authors:	Lee, L, Ronan, E, de Lara, C, Franken, K, Ottenhoff, T, Tchilian, E, Beverley, P
Format:	Journal article
Language:	English
Published:	2011

Similar Items

CXCR6 Is a Marker for Protective Antigen-Specific Cells in the Lungs after Intranasal Immunization against Mycobacterium tuberculosis
by: Lee, L, et al.
Published: (2011)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
by: Tchilian, E, et al.
Published: (2013)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
by: Tchilian, E, et al.
Published: (2013)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
by: Tchilian, E, et al.
Published: (2013)

Simultaneous immunization against tuberculosis.
by: Tchilian, E, et al.
Published: (2011)

Simultaneous immunization against tuberculosis.
by: Tchilian, E, et al.
Published: (2011)

Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection.
by: Sebastian D Schuck, et al.
Published: (2009-01-01)

Antigens of Mycobacterium tuberculosis Stimulate CXCR6+ Natural Killer Cells
by: José Alberto Choreño-Parra, et al.
Published: (2020-09-01)

Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
by: Ronan, E, et al.
Published: (2009)

Immunization of Mice with a Recombinant Adenovirus Vaccine Inhibits the Early Growth of Mycobacterium tuberculosis After Infection
by: Ronan, E, et al.
Published: (2009)

Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine.
by: Ronan, E, et al.
Published: (2010)

Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine.
by: Ronan, E, et al.
Published: (2010)

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.
by: Forbes, E, et al.
Published: (2008)

Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A.
by: Beverley, P, et al.
Published: (2013)

Kinetics of T cell-activation molecules in response to Mycobacterium tuberculosis antigens
by: Antas Paulo RZ, et al.
Published: (2002-01-01)

Significance of Antigen and Epitope Specificity in Tuberculosis
by: Juraj eIvanyi, et al.
Published: (2014-10-01)

Design of Polymeric Nanocapsules for Intranasal Vaccination against Mycobacterium Tuberculosis: Influence of the Polymeric Shell and Antigen Positioning
by: Lara Diego-González, et al.
Published: (2020-05-01)

Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia
by: Leonar Arroyo, et al.
Published: (2018-01-01)

Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis
by: Mªdel Mar eSerra Vidal, et al.
Published: (2014-10-01)

Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
by: Edward O Ronan, et al.
Published: (2009-12-01)

Simultaneous immunization against tuberculosis.
by: Elma Z Tchilian, et al.
Published: (2011-01-01)

Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis.
by: Demissie, A, et al.
Published: (2006)

IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals.
by: Fekadu Abebe, et al.
Published: (2018-01-01)

Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups
by: Mariateresa Coppola, et al.
Published: (2020-02-01)

In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination
by: Mariateresa Coppola, et al.
Published: (2021-06-01)

Machine Learning Algorithms Evaluate Immune Response to Novel Mycobacterium tuberculosis Antigens for Diagnosis of Tuberculosis
by: Noëmi Rebecca Meier, et al.
Published: (2021-01-01)

Dimethyl fumarate eliminates differentially culturable Mycobacterium tuberculosis in an intranasal murine model of tuberculosis
by: Sarah M. Glenn, et al.
Published: (2022-08-01)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
by: Ronan, E
Published: (2011)

A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.
by: Beverley, P, et al.
Published: (2014)

CXCR6-Deficiency Improves the Control of Pulmonary Mycobacterium tuberculosis and Influenza Infection Independent of T-Lymphocyte Recruitment to the Lungs
by: Anneliese S. Ashhurst, et al.
Published: (2019-03-01)

A Systematic Review on Novel Mycobacterium tuberculosis Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis
by: Noëmi R. Meier, et al.
Published: (2018-11-01)

Lessons for tuberculosis vaccines from respiratory virus infection.
by: Beverley, P, et al.
Published: (2008)

Lessons for tuberculosis vaccines from respiratory virus infection
by: Beverley, P, et al.
Published: (2008)

The T cell response to lipid antigens of Mycobacterium tuberculosis
by: Gennaro eDe Libero, et al.
Published: (2014-05-01)

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.
by: Lalvani, A, et al.
Published: (2001)

Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection
by: Weicong Ren, et al.
Published: (2024-03-01)

Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination.
by: Suraj B Sable, et al.
Published: (2011-01-01)

Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis.
by: Smith, S, et al.
Published: (2009)

Study of the antibody response against Mycobacterium tuberculosis antigens in Warao Amerindian children in Venezuela
by: Z Araujo, et al.
Published: (2004-08-01)

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
by: Tchilian, E, et al.
Published: (2009)